Illustrative Smoking-Associated Cardiovascular Risk Tool

Current Value: 10

Current Value: 20

Illustrative Relative CVD Risk Increase (vs. Non-Smoker):

Moderate



Disclaimer: This tool provides a simplified, illustrative estimate of the relative increase in cardiovascular disease (CVD) risk associated with smoking, compared to a non-smoker. The calculation is based on general population trends and reflects the non-linear impact of cigarette quantity (steeper risk increase at lower numbers) and the cumulative effect of smoking duration, as suggested by general research findings.[1, 2, 3]

This tool DOES NOT provide a medical diagnosis, absolute risk prediction, or personalized health advice.

CVD risk is multifactorial and depends on many factors not included in this tool, such as: genetics, age, sex, ethnicity, blood pressure, cholesterol levels (LDL, HDL, non-HDL, Lp(a)), triglycerides, diabetes status, body mass index (BMI), diet, physical activity, alcohol consumption, kidney function, family history, socioeconomic status, and other medical conditions (e.g., rheumatoid arthritis, severe mental illness).

The risk calculation does not replicate complex epidemiological models like QRISK3 or Framingham Risk Score.[4, 5, 6, 7, 8, 9]

Consult a healthcare professional for a comprehensive assessment of your individual CVD risk and personalized medical advice.

Works cited

  1. Low cigarette consumption and risk of coronary heart disease and ..., accessed April 10, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC5781309/
  2. natap.org, accessed April 10, 2025, https://natap.org/2019/HIV/jama_duncan_2019_oi_190077-2.pdf
  3. Cardiovascular Effects of Smoking and Smoking Cessation: A 2024 ..., accessed April 10, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC11843939/
  4. Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus, accessed April 10, 2025, https://pmc.ncbi.nlm.nih.gov/articles/PMC9742415/
  5. Cardiovascular Disease (10-year risk) - Framingham Heart Study, accessed April 10, 2025, https://www.framinghamheartstudy.org/fhs-risk-functions/cardiovascular-disease-10-year-risk/
  6. Assessment of QRISK3 as a predictor of cardiovascular disease events in type 2 diabetes mellitus - Frontiers, accessed April 9, 2025, https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2022.1077632/full
  7. Framingham Risk Calculator, accessed April 10, 2025, https://www.omnicalculator.com/health/framingham-risk
  8. Development and validation of QRISK3 risk prediction algorithms to estimate future risk of cardiovascular disease: prospective cohort study | The BMJ, accessed April 10, 2025, https://www.bmj.com/content/357/bmj.j2099

Framingham Risk Score (2008) - Medscape, accessed April 10, 2025, https://reference.medscape.com/calculator/252/framingham-risk-score-2008

Similar Posts